December 10, 2019 at 1:14 pm

FDA’s Fast-Tracked Drugs May Pose Increased Risks

A new study finds pharmaceutical products rushed through an expedited FDA approved process are “48% more likely to get either a black-box warning or to receive contraindications that restrict the drug’s use.”
Read the full story here.